Here’s why sodium-ion batteries are shaping up to be a big technology breakthrough
Although still in its infancy, the global market for sodium-ion batteries is expected to be worth over $11 billion by 2033.
HSBC downgrades Anheuser-Busch InBev as it deals with a ‘Bud Light crisis’
The analyst cited research that showed a steep drop in April beer sales after the company’s partnership with a transgender influencer resulted in a backlash.
Mortgage demand surged after Fed signaled potential pause in rate hikes
Mortgage demand rose last week after interest rates pulled back slightly. Demand is still far lower, however, than it was a year ago.
Barclays downgrades shares of this laser maker following ‘one too many resets’
The company’s latest quarterly results and guidance fell below analysts’ expectations.
Rivian Automotive’s results are encouraging, though concerns remain, analysts say
Rivian made its initial public debut in 2021, and has cratered in the years since as it dealt with rising interest rates that dimmed its growth prospects.
Ford reveals redesigned Ranger pickup with new Raptor performance model
The addition of the Raptor — starting at $56,960 — is part of Ford’s plan to increase high-profit variants to boost its bottom line.
Twilio stock falls on weaker-than-expected revenue forecast
Twilio is gaining customers, but some users are opting not to increase their spending because of economic fears.
New college graduates are overestimating their starting salaries by $30,000, report finds
Today’s undergrads expect to make nearly $85,000 one year after graduation. Yet, the average starting salary for recent graduates is closer to $55,000.
Fed’s John Williams says rates could be increased if inflation doesn’t come down
The current problems in the banking industry and their impact will factor into Williams’ policy outlook.
This unique biotech play should rally more than 35% ahead, BTIG says
The Wall Street firm said this stock is a category leader for model-informed drug development (MIDD), or simulations for biotech drug trials.
